Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism. Barath B, Bogati R, Miklos T, Kallai J, et al. Thromb Res 2021;203:110-116.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barath B, Bogati R, Miklos T, Kallai J, et al. Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism. Thromb Res 2021;203:110-116.
PMID: 33992873